Verition Fund Management LLC Akoya Biosciences, Inc. Transaction History
Verition Fund Management LLC
- $19.9 Billion
- Q1 2025
A detailed history of Verition Fund Management LLC transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 166,314 shares of AKYA stock, worth $166,314. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166,314Holding current value
$166,314% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding AKYA
# of Institutions
65Shares Held
12.4MCall Options Held
40.4KPut Options Held
1K-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$4.7 Million6.47% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$1.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$1.39 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX671KShares$671,0002.35% of portfolio
-
Geode Capital Management, LLC Boston, MA567KShares$566,9820.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $37.9M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...